Yann Echelard is Director of TG THERAPEUTICS, INC.. Currently has a direct ownership of 224,098 shares of TGTX, which is worth approximately $7.29 Million. The most recent transaction as insider was on Nov 05, 2024, when has been sold 20,000 shares (Common Stock) at a price of $24.48 per share, resulting in proceeds of $489,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 224K
8.19% 3M change
1.01% 12M change
Total Value Held $7.29 Million

Yann Echelard Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 05 2024
SELL
Open market or private sale
$489,600 $24.48 p/Share
20,000 Reduced 8.19%
224,098 Common Stock
Jun 19 2024
BUY
Grant, award, or other acquisition
-
22,250 Added 8.35%
244,098 Common Stock
Sep 28 2023
BUY
Grant, award, or other acquisition
-
20,000 Added 8.27%
221,848 Common Stock
Jan 06 2023
BUY
Open market or private purchase
$95,760 $10.64 p/Share
9,000 Added 4.27%
201,848 Common Stock
Jul 20 2022
BUY
Grant, award, or other acquisition
-
43,732 Added 18.49%
192,848 Common Stock
Jun 18 2021
BUY
Grant, award, or other acquisition
-
20,000 Added 11.83%
149,116 Common Stock
Dec 10 2020
SELL
Open market or private sale
$1,201,500 $40.05 p/Share
30,000 Reduced 18.85%
129,116 Common Stock
YE

Yann Echelard

Director
New York, NY

Track Institutional and Insider Activities on TGTX

Follow TG THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TGTX shares.

Notify only if

Insider Trading

Get notified when an Tg Therapeutics, Inc. insider buys or sells TGTX shares.

Notify only if

News

Receive news related to TG THERAPEUTICS, INC.

Track Activities on TGTX